Project description
Enhancing Cyprus' biobank will support the country's own Human Genome Project
The term biobank first appeared in the literature in the 1990s. Since then, the number of biobanks worldwide has grown tremendously. These repositories of biological samples and data are associated with hospitals, research institutions, pharmaceutical companies and even patient organisations. They are playing an increasingly important role in healthcare research and delivery, particularly in personalised medicine. Genetically similar populations benefit from having their own repositories but Cyprus, as the last EU-member country to establish a biobank, is limited in its current patient samples and data. The EU-funded CY-BIOBANK project is helping Cyprus significantly enhance its repository and promote research to benefit its citizens and their healthcare delivery by supporting the Cyprus Human Genome Project.
Objective
The genetic investigation of diseases and eHealth are a priority of the Smart Specialization Strategy of Cyprus. The strategy can best be served by creating a Centre of Excellence (CoE) with two pillars: a) A contemporary Biobank research infrastructure that incorporates eHealth; b) a state-of-the-art research facility to support the Cyprus Human Genome Project and drive translational research, focused on genetic diseases, thus enhancing the European Research Area.
Biobanks are organized collections of medical records and biospecimens, aimed to support biomedical research, serving as repositories and distribution centers. Biobanking and genomics infrastructures in Cyprus are lagging behind of European levels, thus limiting the prospects for research and innovation potential. The CY-Biobank shall upgrade the existing infrastructure, implementing high standard procedures and quality management systems for safeguarding data and material of the highest trustworthiness, for downstream investigations. The CoE will embrace the entire research community of Cyprus and serve as an incubator for innovative ideas and as a tertiary medical and educational institute for the rare monogenic and frequent complex disorders, aimed at better patient care and precision medicine. The CY-Biobank will adopt a patient-centric approach showing respect to sensitive ethical, legal and social issues, with the involvement of all stakeholders in the medical and patients’ communities. The CoE aspires also to play a broader role by forming the MediEuro Network with countries in the Mediterranean and the Middle East, thus complementing efforts for bridging EU to this part of the world. The Advanced Partners are the Medical University of Graz that coordinated the preparatory phase of the project for Biobanking & BioMolecular resources Research Infrastructure (BBMRI) and its subsequent European Research Infrastructure Consortium, BBMRI-ERIC, which represents the largest family of Biobanks in Europe.
Fields of science
Keywords
Programme(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
1678 Nicosia
Cyprus